APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Pharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pet Pharmaceuticals Industry Growth and Trends Forecast to 2032

28 December 2025101 pages

Choose your research edition.

Industry ResearchPet Pharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Pharmaceuticals Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pet Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Pharmaceuticals Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Pharmaceuticals Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Pharmaceuticals market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Pharmaceuticals include CAHIC, Chopperlvya Animal Health, Merck, Jindun, Zoetis, Virbac, Vetoquinol, Ouro Fino Saude and Norbrook, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pet Pharmaceuticals market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pet Pharmaceuticals market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Pharmaceuticals market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Pharmaceuticals.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pet Pharmaceuticals market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pet Pharmaceuticals Market by Company

CAHIC

Chopperlvya Animal Health

Merck

Jindun

Zoetis

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Elanco

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Pet Pharmaceuticals Segment by Type

Antiparasitic

Antibacterial

Biological Products

Others

Pet Pharmaceuticals Segment by Application

Prevention

Treatment

Pet Pharmaceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Pharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pet Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antiparasitic Table 2. Major Company of Antibacterial Table 3. Major Company of Biological Products Table 4. Major Company of Others Table 5. Global Pet Pharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 7. Global Pet Pharmaceuticals Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pet Pharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pet Pharmaceuticals Sales Market Share in Value by Type (2021-2026) Table 10. Global Pet Pharmaceuticals Price by Type (2021-2026) & (US$/Unit) Table 11. Global Pet Pharmaceuticals Sales by Type (2027-2032) & (K Units) Table 12. Global Pet Pharmaceuticals Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pet Pharmaceuticals Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pet Pharmaceuticals Sales Market Share in Value by Type (2027-2032) Table 15. Global Pet Pharmaceuticals Price by Type (2027-2032) & (US$/Unit) Table 16. North America Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 17. North America Pet Pharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 19. Europe Pet Pharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Pet Pharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 23. Latin America Pet Pharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Pet Pharmaceuticals Sales by Type (2021-2026) & (US$ Million) Table 26. Pet Pharmaceuticals Industry Trends Table 27. Pet Pharmaceuticals Industry Drivers Table 28. Pet Pharmaceuticals Industry Opportunities and Challenges Table 29. Pet Pharmaceuticals Industry Restraints Table 30. Global Pet Pharmaceuticals Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pet Pharmaceuticals Revenue Market Share by Company (2021-2026) Table 32. Global Pet Pharmaceuticals Sales by Company (2021-2026) & (K Units) Table 33. Global Pet Pharmaceuticals Sales Share by Company (2021-2026) Table 34. Global Pet Pharmaceuticals Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Pet Pharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pet Pharmaceuticals Major Company Production Sites and Headquarters Table 37. Global Pet Pharmaceuticals Company, Product Type & Application Table 38. Global Pet Pharmaceuticals Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pet Pharmaceuticals Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pet Pharmaceuticals Sales by Region (2021-2026) & (K Units) Table 43. Global Pet Pharmaceuticals Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pet Pharmaceuticals Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pet Pharmaceuticals Sales Market Share in Value by Region (2021-2026) Table 46. Global Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Pet Pharmaceuticals Sales by Region (2027-2032) & (K Units) Table 48. Global Pet Pharmaceuticals Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pet Pharmaceuticals Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pet Pharmaceuticals Sales Market Share in Value by Region (2027-2032) Table 51. Global Pet Pharmaceuticals Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Pet Pharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 54. Global Pet Pharmaceuticals Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pet Pharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pet Pharmaceuticals Sales Market Share in Value by Application (2021-2026) Table 57. Global Pet Pharmaceuticals Price by Application (2021-2026) & (US$/Unit) Table 58. Global Pet Pharmaceuticals Sales by Application (2027-2032) & (K Units) Table 59. Global Pet Pharmaceuticals Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pet Pharmaceuticals Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pet Pharmaceuticals Sales Market Share in Value by Application (2027-2032) Table 62. Global Pet Pharmaceuticals Price by Application (2027-2032) & (US$/Unit) Table 63. North America Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 64. North America Pet Pharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 66. Europe Pet Pharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Pet Pharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 70. Latin America Pet Pharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Pet Pharmaceuticals Sales by Application (2021-2026) & (US$ Million) Table 73. CAHIC Company Information Table 74. CAHIC Business Overview Table 75. CAHIC Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. CAHIC Pet Pharmaceuticals Product Portfolio Table 77. CAHIC Recent Development Table 78. Chopperlvya Animal Health Company Information Table 79. Chopperlvya Animal Health Business Overview Table 80. Chopperlvya Animal Health Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio Table 82. Chopperlvya Animal Health Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Pet Pharmaceuticals Product Portfolio Table 87. Merck Recent Development Table 88. Jindun Company Information Table 89. Jindun Business Overview Table 90. Jindun Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jindun Pet Pharmaceuticals Product Portfolio Table 92. Jindun Recent Development Table 93. Zoetis Company Information Table 94. Zoetis Business Overview Table 95. Zoetis Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Zoetis Pet Pharmaceuticals Product Portfolio Table 97. Zoetis Recent Development Table 98. Virbac Company Information Table 99. Virbac Business Overview Table 100. Virbac Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Virbac Pet Pharmaceuticals Product Portfolio Table 102. Virbac Recent Development Table 103. Vetoquinol Company Information Table 104. Vetoquinol Business Overview Table 105. Vetoquinol Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Vetoquinol Pet Pharmaceuticals Product Portfolio Table 107. Vetoquinol Recent Development Table 108. Ouro Fino Saude Company Information Table 109. Ouro Fino Saude Business Overview Table 110. Ouro Fino Saude Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Ouro Fino Saude Pet Pharmaceuticals Product Portfolio Table 112. Ouro Fino Saude Recent Development Table 113. Norbrook Company Information Table 114. Norbrook Business Overview Table 115. Norbrook Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Norbrook Pet Pharmaceuticals Product Portfolio Table 117. Norbrook Recent Development Table 118. Elanco Company Information Table 119. Elanco Business Overview Table 120. Elanco Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Elanco Pet Pharmaceuticals Product Portfolio Table 122. Elanco Recent Development Table 123. Dechra Veterinary Products Company Information Table 124. Dechra Veterinary Products Business Overview Table 125. Dechra Veterinary Products Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio Table 127. Dechra Veterinary Products Recent Development Table 128. Ceva Company Information Table 129. Ceva Business Overview Table 130. Ceva Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Ceva Pet Pharmaceuticals Product Portfolio Table 132. Ceva Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. North America Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. North America Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 140. North America Pet Pharmaceuticals Sales Market Share by Country (2021-2026) Table 141. North America Pet Pharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 142. North America Pet Pharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 143. North America Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Pet Pharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Pet Pharmaceuticals Market Share by Country (2021-2026) Table 146. North America Pet Pharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Pet Pharmaceuticals Market Share Forecast by Country (2027-2032) Table 148. Europe Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Europe Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 150. Europe Pet Pharmaceuticals Sales Market Share by Country (2021-2026) Table 151. Europe Pet Pharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 152. Europe Pet Pharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Pet Pharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Pet Pharmaceuticals Market Share by Country (2021-2026) Table 156. Europe Pet Pharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Pet Pharmaceuticals Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 160. Asia-Pacific Pet Pharmaceuticals Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Pet Pharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 162. Asia-Pacific Pet Pharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Pet Pharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Pet Pharmaceuticals Market Share by Country (2021-2026) Table 166. Asia-Pacific Pet Pharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Pet Pharmaceuticals Market Share Forecast by Country (2027-2032) Table 168. Latin America Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Latin America Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 170. Latin America Pet Pharmaceuticals Sales Market Share by Country (2021-2026) Table 171. Latin America Pet Pharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 172. Latin America Pet Pharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Pet Pharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Pet Pharmaceuticals Market Share by Country (2021-2026) Table 176. Latin America Pet Pharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Pet Pharmaceuticals Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 180. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Pet Pharmaceuticals Sales Forecast by Country (2027-2032) & (K Units) Table 182. Middle East and Africa Pet Pharmaceuticals Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Pet Pharmaceuticals Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Pet Pharmaceuticals Market Share by Country (2021-2026) Table 186. Middle East and Africa Pet Pharmaceuticals Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Pet Pharmaceuticals Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Pet Pharmaceuticals Distributors List Table 191. Pet Pharmaceuticals Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Pet Pharmaceuticals Image Figure 2. Global Pet Pharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Pharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Pharmaceuticals Sales (2021-2032) & (K Units) Figure 5. Antiparasitic Image Figure 6. Global Antiparasitic Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antibacterial Image Figure 8. Global Antibacterial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Biological Products Image Figure 10. Global Biological Products Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Pet Pharmaceuticals Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pet Pharmaceuticals Market Share by Type 2025 VS 2032 Figure 15. North America Pet Pharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 16. North America Pet Pharmaceuticals Sales Market Share in Value by Type in 2025 Figure 17. Europe Pet Pharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pet Pharmaceuticals Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pet Pharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pet Pharmaceuticals Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pet Pharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pet Pharmaceuticals Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pet Pharmaceuticals Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pet Pharmaceuticals Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pet Pharmaceuticals Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Prevention Image Figure 28. Global Prevention Sales YoY Growth (2021-2032) & (K Units) Figure 29. Treatment Image Figure 30. Global Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pet Pharmaceuticals Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pet Pharmaceuticals Market Share by Application 2025 VS 2032 Figure 33. North America Pet Pharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 34. North America Pet Pharmaceuticals Sales Market Share in Value by Application in 2025 Figure 35. Europe Pet Pharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pet Pharmaceuticals Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pet Pharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pet Pharmaceuticals Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pet Pharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pet Pharmaceuticals Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pet Pharmaceuticals Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pet Pharmaceuticals Sales Market Share in Value by Application in 2025 Figure 43. North America Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pet Pharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pet Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pet Pharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pet Pharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pet Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pet Pharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pet Pharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pet Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pet Pharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pet Pharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pet Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pet Pharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pet Pharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pet Pharmaceuticals Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pet Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pet Pharmaceuticals Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pet Pharmaceuticals Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pet Pharmaceuticals Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Antiparasitic
  • Antibacterial
  • Biological Products
  • Others
Applications
  • Prevention
  • Treatment
Companies covered
  • CAHIC
  • Chopperlvya Animal Health
  • Merck
  • Jindun
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Pharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pet Pharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pet Pharmaceuticals Market by Type
  6. 1.3.1 Antiparasitic
  7. 1.3.2 Antibacterial
  8. 1.3.3 Biological Products
  9. 1.3.4 Others
  10. 1.4 Global Pet Pharmaceuticals Market Size by Type
  11. 1.4.1 Global Pet Pharmaceuticals Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pet Pharmaceuticals Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pet Pharmaceuticals Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pet Pharmaceuticals Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pet Pharmaceuticals Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pet Pharmaceuticals Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pet Pharmaceuticals Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pet Pharmaceuticals Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pet Pharmaceuticals Industry Trends
  2. 2.2 Pet Pharmaceuticals Industry Drivers
  3. 2.3 Pet Pharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Pet Pharmaceuticals Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pet Pharmaceuticals Revenue (2021-2026)
  2. 3.2 Global Top Players by Pet Pharmaceuticals Sales (2021-2026)
  3. 3.3 Global Top Players by Pet Pharmaceuticals Price (2021-2026)
  4. 3.4 Global Pet Pharmaceuticals Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Pharmaceuticals Major Company Production Sites & Headquarters
  6. 3.6 Global Pet Pharmaceuticals Company, Product Type & Application
  7. 3.7 Global Pet Pharmaceuticals Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Pharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Pharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Pharmaceuticals Tier 1, Tier 2, and Tier 3
4 Pet Pharmaceuticals Regional Status and Outlook
  1. 4.1 Global Pet Pharmaceuticals Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pet Pharmaceuticals Historic Market Size by Region
  3. 4.2.1 Global Pet Pharmaceuticals Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pet Pharmaceuticals Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pet Pharmaceuticals Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pet Pharmaceuticals Forecasted Market Size by Region
  7. 4.3.1 Global Pet Pharmaceuticals Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pet Pharmaceuticals Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pet Pharmaceuticals Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Pharmaceuticals by Application
  1. 5.1 Pet Pharmaceuticals Market by Application
  2. 5.1.1 Prevention
  3. 5.1.2 Treatment
  4. 5.2 Global Pet Pharmaceuticals Market Size by Application
  5. 5.2.1 Global Pet Pharmaceuticals Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pet Pharmaceuticals Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pet Pharmaceuticals Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Pet Pharmaceuticals Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Pet Pharmaceuticals Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Pet Pharmaceuticals Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Pet Pharmaceuticals Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Pet Pharmaceuticals Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CAHIC
  2. 6.1.1 CAHIC Company Information
  3. 6.1.2 CAHIC Business Overview
  4. 6.1.3 CAHIC Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CAHIC Pet Pharmaceuticals Product Portfolio
  6. 6.1.5 CAHIC Recent Developments
  7. 6.2 Chopperlvya Animal Health
  8. 6.2.1 Chopperlvya Animal Health Company Information
  9. 6.2.2 Chopperlvya Animal Health Business Overview
  10. 6.2.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio
  12. 6.2.5 Chopperlvya Animal Health Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Pet Pharmaceuticals Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Jindun
  20. 6.4.1 Jindun Company Information
  21. 6.4.2 Jindun Business Overview
  22. 6.4.3 Jindun Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jindun Pet Pharmaceuticals Product Portfolio
  24. 6.4.5 Jindun Recent Developments
  25. 6.5 Zoetis
  26. 6.5.1 Zoetis Company Information
  27. 6.5.2 Zoetis Business Overview
  28. 6.5.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zoetis Pet Pharmaceuticals Product Portfolio
  30. 6.5.5 Zoetis Recent Developments
  31. 6.6 Virbac
  32. 6.6.1 Virbac Company Information
  33. 6.6.2 Virbac Business Overview
  34. 6.6.3 Virbac Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Virbac Pet Pharmaceuticals Product Portfolio
  36. 6.6.5 Virbac Recent Developments
  37. 6.7 Vetoquinol
  38. 6.7.1 Vetoquinol Company Information
  39. 6.7.2 Vetoquinol Business Overview
  40. 6.7.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vetoquinol Pet Pharmaceuticals Product Portfolio
  42. 6.7.5 Vetoquinol Recent Developments
  43. 6.8 Ouro Fino Saude
  44. 6.8.1 Ouro Fino Saude Company Information
  45. 6.8.2 Ouro Fino Saude Business Overview
  46. 6.8.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ouro Fino Saude Pet Pharmaceuticals Product Portfolio
  48. 6.8.5 Ouro Fino Saude Recent Developments
  49. 6.9 Norbrook
  50. 6.9.1 Norbrook Company Information
  51. 6.9.2 Norbrook Business Overview
  52. 6.9.3 Norbrook Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Norbrook Pet Pharmaceuticals Product Portfolio
  54. 6.9.5 Norbrook Recent Developments
  55. 6.10 Elanco
  56. 6.10.1 Elanco Company Information
  57. 6.10.2 Elanco Business Overview
  58. 6.10.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Elanco Pet Pharmaceuticals Product Portfolio
  60. 6.10.5 Elanco Recent Developments
  61. 6.11 Dechra Veterinary Products
  62. 6.11.1 Dechra Veterinary Products Company Information
  63. 6.11.2 Dechra Veterinary Products Business Overview
  64. 6.11.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio
  66. 6.11.5 Dechra Veterinary Products Recent Developments
  67. 6.12 Ceva
  68. 6.12.1 Ceva Company Information
  69. 6.12.2 Ceva Business Overview
  70. 6.12.3 Ceva Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ceva Pet Pharmaceuticals Product Portfolio
  72. 6.12.5 Ceva Recent Developments
  73. 6.13 Boehringer Ingelheim
  74. 6.13.1 Boehringer Ingelheim Company Information
  75. 6.13.2 Boehringer Ingelheim Business Overview
  76. 6.13.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio
  78. 6.13.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Pet Pharmaceuticals Sales by Country
  2. 7.1.1 North America Pet Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pet Pharmaceuticals Sales by Country (2021-2026)
  4. 7.1.3 North America Pet Pharmaceuticals Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pet Pharmaceuticals Market Size by Country
  6. 7.2.1 North America Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pet Pharmaceuticals Market Size by Country (2021-2026)
  8. 7.2.3 North America Pet Pharmaceuticals Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pet Pharmaceuticals Sales by Country
  2. 8.1.1 Europe Pet Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pet Pharmaceuticals Sales by Country (2021-2026)
  4. 8.1.3 Europe Pet Pharmaceuticals Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pet Pharmaceuticals Market Size by Country
  6. 8.2.1 Europe Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pet Pharmaceuticals Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pet Pharmaceuticals Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pet Pharmaceuticals Sales by Country
  2. 9.1.1 Asia-Pacific Pet Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pet Pharmaceuticals Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pet Pharmaceuticals Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pet Pharmaceuticals Market Size by Country
  6. 9.2.1 Asia-Pacific Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pet Pharmaceuticals Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pet Pharmaceuticals Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pet Pharmaceuticals Sales by Country
  2. 10.1.1 South America Pet Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pet Pharmaceuticals Sales by Country (2021-2026)
  4. 10.1.3 South America Pet Pharmaceuticals Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pet Pharmaceuticals Market Size by Country
  6. 10.2.1 South America Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pet Pharmaceuticals Market Size by Country (2021-2026)
  8. 10.2.3 South America Pet Pharmaceuticals Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pet Pharmaceuticals Sales by Country
  2. 11.1.1 Middle East and Africa Pet Pharmaceuticals Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pet Pharmaceuticals Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pet Pharmaceuticals Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pet Pharmaceuticals Market Size by Country
  6. 11.2.1 Middle East and Africa Pet Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pet Pharmaceuticals Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pet Pharmaceuticals Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pet Pharmaceuticals Value Chain Analysis
  2. 12.1.1 Pet Pharmaceuticals Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pet Pharmaceuticals Production Mode & Process
  7. 12.2 Pet Pharmaceuticals Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pet Pharmaceuticals Distributors
  10. 12.2.3 Pet Pharmaceuticals Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst